Product Information
OXAZEPAM 30 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $1.1370 per EA under NDC 00228207310. Its NADAC has been published 587 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228207310
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA072253On Market Since
1/2/2007
Pharmacological Classes
Price Statistics
The NADAC for OXAZEPAM 30 MG CAPSULE has been published 587 times since Nov 28, 2013, and over the history we have for it it has declined 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1370 per EA |
|---|---|
| All-time high | $1.5994 (Apr 13, 2016) |
| All-time low | $1.0556 (Feb 18, 2015) |
| 52-week high | $1.4027 |
| 52-week low | $1.1218 |
| Median price | $1.3449 |
| Average price | $1.3393 |
| Largest weekly change | +34.0% (Dec 23, 2015) |
| Weeks tracked | 587 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXAZEPAM 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OXAZEPAM 30 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $1.1370 per EA (NDC 00228207310), effective Jun 24, 2026.
How has the price of OXAZEPAM 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OXAZEPAM 30 MG CAPSULE has declined 10.9%. It has been tracked across 587 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OXAZEPAM 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for OXAZEPAM 30 MG CAPSULE has ranged from a low of $1.0556 (Feb 18, 2015) to a high of $1.5994 (Apr 13, 2016), with a median of $1.3449 per EA.
Are there cheaper alternatives to OXAZEPAM 30 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as OXAZEPAM 30 MG CAPSULE, but none are currently priced below it.
Who manufactures OXAZEPAM 30 MG CAPSULE?
OXAZEPAM 30 MG CAPSULE (NDC 00228207310) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification